2014 Annual Meeting | 7MS.005 - Mild Cognitive Impairment: Implications for Clinicians
06:30 AM - 06:35 AM |
Introduction
David J. Gill, MD, FAAN |
|
06:35 AM - 07:20 AM |
Clinical Overview of Mild Cognitive Impairment
Ronald C. Petersen, MD, PhD, FAAN |
|
07:20 AM - 08:00 AM |
Prediction of Outcome and Treatment of Mild Cognitive Impairment
David J. Gill, MD, FAAN |
David J. Gill, MD, FAAN | Dr. Gill has nothing to disclose. |
Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |